Albee Messing - Publications

Affiliations: 
Comparative Biosciences University of Wisconsin, Madison, Madison, WI 
Website:
http://www.waisman.wisc.edu/FACULTY/messing.html

146 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Helman G, Van Haren K, Bonkowsky JL, Bernard G, Pizzino A, Braverman N, Suhr D, Patterson MC, Ali Fatemi S, Leonard J, van der Knaap MS, Back SA, Damiani S, Goldman SA, Takanohashi A, ... ... Messing A, et al. Disease specific therapies in leukodystrophies and leukoencephalopathies. Molecular Genetics and Metabolism. 114: 527-36. PMID 25684057 DOI: 10.1016/j.ymgme.2015.01.014  1
2015 Brenner M, Messing A. A new mutation in GFAP widens the spectrum of Alexander disease. European Journal of Human Genetics : Ejhg. 23: 1-2. PMID 24961628 DOI: 10.1038/ejhg.2014.99  1
2014 Cotrina ML, Chen M, Han X, Iliff J, Ren Z, Sun W, Hagemann T, Goldman J, Messing A, Nedergaard M. Effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of Alexander disease. Brain Research. 1582: 211-9. PMID 25069089 DOI: 10.1016/j.brainres.2014.07.029  1
2014 Walker AK, Daniels CM, Goldman JE, Trojanowski JQ, Lee VM, Messing A. Astrocytic TDP-43 pathology in Alexander disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 6448-58. PMID 24806671 DOI: 10.1523/JNEUROSCI.0248-14.2014  1
2014 Brenner M, Messing A. Alexander disease and astrotherapeutics Pathological Potential of Neuroglia: Possible New Targets For Medical Intervention. 89-105. DOI: 10.1007/978-1-4939-0974-2-5  1
2013 Hagemann TL, Paylor R, Messing A. Deficits in adult neurogenesis, contextual fear conditioning, and spatial learning in a Gfap mutant mouse model of Alexander disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18698-706. PMID 24259590 DOI: 10.1523/JNEUROSCI.3693-13.2013  1
2013 Chen MH, Hagemann TL, Quinlan RA, Messing A, Perng MD. Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation. Asn Neuro. 5: e00125. PMID 24102621 DOI: 10.1042/AN20130032  1
2013 Yeo S, Bandyopadhyay S, Messing A, Brenner M. Transgenic analysis of GFAP promoter elements. Glia. 61: 1488-99. PMID 23832770 DOI: 10.1002/glia.22536  1
2013 Jany PL, Hagemann TL, Messing A. GFAP expression as an indicator of disease severity in mouse models of Alexander disease. Asn Neuro. 5: e00109. PMID 23432455 DOI: 10.1042/AN20130003  1
2013 Cunningham R, Jany P, Messing A, Li L. Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry. Journal of Proteome Research. 12: 719-28. PMID 23272901 DOI: 10.1021/pr300785h  1
2012 Toops KA, Hagemann TL, Messing A, Nickells RW. The effect of glial fibrillary acidic protein expression on neurite outgrowth from retinal explants in a permissive environment. Bmc Research Notes. 5: 693. PMID 23259929 DOI: 10.1186/1756-0500-5-693  1
2012 LaPash Daniels CM, Austin EV, Rockney DE, Jacka EM, Hagemann TL, Johnson DA, Johnson JA, Messing A. Beneficial effects of Nrf2 overexpression in a mouse model of Alexander disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 10507-15. PMID 22855800 DOI: 10.1523/JNEUROSCI.1494-12.2012  1
2012 Hagemann TL, Jobe EM, Messing A. Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival. Plos One. 7: e37304. PMID 22693571 DOI: 10.1371/journal.pone.0037304  1
2012 Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE. Alexander disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 5017-23. PMID 22496548 DOI: 10.1523/JNEUROSCI.5384-11.2012  1
2012 Flint D, Li R, Webster LS, Naidu S, Kolodny E, Percy A, van der Knaap M, Powers JM, Mantovani JF, Ekstein J, Goldman JE, Messing A, Brenner M. Splice site, frameshift, and chimeric GFAP mutations in Alexander disease. Human Mutation. 33: 1141-8. PMID 22488673 DOI: 10.1002/humu.22094  1
2012 Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodríguez JJ, Nedergaard M. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. Asn Neuro. 4. PMID 22339481 DOI: 10.1042/AN20120010  1
2012 Messing A, Li R, Naidu S, Taylor JP, Silverman L, Flint D, van der Knaap MS, Brenner M. Archetypal and new families with Alexander disease and novel mutations in GFAP. Archives of Neurology. 69: 208-14. PMID 21987397 DOI: 10.1001/archneurol.2011.1181  1
2011 Prust M, Wang J, Morizono H, Messing A, Brenner M, Gordon E, Hartka T, Sokohl A, Schiffmann R, Gordish-Dressman H, Albin R, Amartino H, Brockman K, Dinopoulos A, Dotti MT, et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology. 77: 1287-94. PMID 21917775 DOI: 10.1212/WNL.0b013e3182309f72  1
2011 Duarri A, Lopez de Heredia M, Capdevila-Nortes X, Ridder MC, Montolio M, López-Hernández T, Boor I, Lien CF, Hagemann T, Messing A, Gorecki DC, Scheper GC, Martínez A, Nunes V, van der Knaap MS, et al. Knockdown of MLC1 in primary astrocytes causes cell vacuolation: a MLC disease cell model. Neurobiology of Disease. 43: 228-38. PMID 21440627 DOI: 10.1016/j.nbd.2011.03.015  1
2011 Fratta P, Saveri P, Zambroni D, Ferri C, Tinelli E, Messing A, D'Antonio M, Feltri ML, Wrabetz L. P0S63del impedes the arrival of wild-type P0 glycoprotein to myelin in CMT1B mice. Human Molecular Genetics. 20: 2081-90. PMID 21363884 DOI: 10.1093/hmg/ddr081  1
2011 Cengiz P, Kleman N, Uluc K, Kendigelen P, Hagemann T, Akture E, Messing A, Ferrazzano P, Sun D. Inhibition of Na+/H+ exchanger isoform 1 is neuroprotective in neonatal hypoxic ischemic brain injury. Antioxidants & Redox Signaling. 14: 1803-13. PMID 20712402 DOI: 10.1089/ars.2010.3468  1
2010 Yang JH, Wada A, Yoshida K, Miyoshi Y, Sayano T, Esaki K, Kinoshita MO, Tomonaga S, Azuma N, Watanabe M, Hamase K, Zaitsu K, Machida T, Messing A, Itohara S, et al. Brain-specific Phgdh deletion reveals a pivotal role for L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate receptor co-agonist, in adult brain. The Journal of Biological Chemistry. 285: 41380-90. PMID 20966073 DOI: 10.1074/jbc.M110.187443  1
2010 Messing A, LaPash Daniels CM, Hagemann TL. Strategies for treatment in Alexander disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 7: 507-15. PMID 20880512 DOI: 10.1016/j.nurt.2010.05.013  1
2010 Meisingset TW, Risa Ø, Brenner M, Messing A, Sonnewald U. Alteration of glial-neuronal metabolic interactions in a mouse model of Alexander disease. Glia. 58: 1228-34. PMID 20544858 DOI: 10.1002/glia.21003  1
2010 Cho W, Brenner M, Peters N, Messing A. Drug screening to identify suppressors of GFAP expression. Human Molecular Genetics. 19: 3169-78. PMID 20538881 DOI: 10.1093/hmg/ddq227  1
2010 Tian R, Wu X, Hagemann TL, Sosunov AA, Messing A, McKhann GM, Goldman JE. Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes. Journal of Neuropathology and Experimental Neurology. 69: 335-45. PMID 20448479 DOI: 10.1097/NEN.0b013e3181d3cb52  1
2010 Tian R, Wu X, Sosunov AA, McKhann GM, Hagemann TL, Messing A, Goldman JE. Authors' reply Journal of Neuropathology and Experimental Neurology. 69: 1270-1271. DOI: 10.1097/01.JNEN.0000391058.78883.ab  1
2009 Liem RK, Messing A. Dysfunctions of neuronal and glial intermediate filaments in disease. The Journal of Clinical Investigation. 119: 1814-24. PMID 19587456 DOI: 10.1172/JCI38003  1
2009 Cho W, Hagemann TL, Johnson DA, Johnson JA, Messing A. Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary acidic protein. Journal of Neurochemistry. 110: 343-51. PMID 19457099 DOI: 10.1111/j.1471-4159.2009.06146.x  1
2009 Cho W, Messing A. Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice. Experimental Cell Research. 315: 1260-72. PMID 19146851 DOI: 10.1016/j.yexcr.2008.12.012  1
2009 Hagemann TL, Boelens WC, Wawrousek EF, Messing A. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Human Molecular Genetics. 18: 1190-9. PMID 19129171 DOI: 10.1093/hmg/ddp013  1
2009 Brenner M, Goldman JE, Quinlan RA, Messing A. Alexander disease: A genetic disorder of astrocytes Astrocytes in (Patho)Physiology of the Nervous System. 591-648. DOI: 10.1007/978-0-387-79492-1-24  1
2008 Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13574-81. PMID 19074031 DOI: 10.1523/JNEUROSCI.4099-08.2008  1
2008 Tang G, Yue Z, Talloczy Z, Hagemann T, Cho W, Messing A, Sulzer DL, Goldman JE. Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Human Molecular Genetics. 17: 1540-55. PMID 18276609 DOI: 10.1093/hmg/ddn042  1
2008 Lee Y, Messing A, Su M, Brenner M. GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia. 56: 481-93. PMID 18240313 DOI: 10.1002/glia.20622  1
2007 Zou W, Kim BO, Zhou BY, Liu Y, Messing A, He JJ. Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. The American Journal of Pathology. 171: 1923-35. PMID 18055541 DOI: 10.2353/ajpath.2007.070333  1
2007 Douglas CL, Vyazovskiy V, Southard T, Chiu SY, Messing A, Tononi G, Cirelli C. Sleep in Kcna2 knockout mice. Bmc Biology. 5: 42. PMID 17925011 DOI: 10.1186/1741-7007-5-42  1
2007 Brew HM, Gittelman JX, Silverstein RS, Hanks TD, Demas VP, Robinson LC, Robbins CA, McKee-Johnson J, Chiu SY, Messing A, Tempel BL. Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons. Journal of Neurophysiology. 98: 1501-25. PMID 17634333 DOI: 10.1152/jn.00640.2006  1
2007 Quinlan RA, Brenner M, Goldman JE, Messing A. GFAP and its role in Alexander disease. Experimental Cell Research. 313: 2077-87. PMID 17498694 DOI: 10.1016/j.yexcr.2007.04.004  1
2006 Hagemann TL, Connor JX, Messing A. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 11162-73. PMID 17065456 DOI: 10.1523/JNEUROSCI.3260-06.2006  1
2006 Pannasch U, Färber K, Nolte C, Blonski M, Yan Chiu S, Messing A, Kettenmann H. The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia. Molecular and Cellular Neurosciences. 33: 401-11. PMID 17055293 DOI: 10.1016/j.mcn.2006.08.009  1
2006 Triolo D, Dina G, Lorenzetti I, Malaguti M, Morana P, Del Carro U, Comi G, Messing A, Quattrini A, Previtali SC. Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. Journal of Cell Science. 119: 3981-93. PMID 16988027 DOI: 10.1242/jcs.03168  1
2006 Jeng LJ, Balice-Gordon RJ, Messing A, Fischbeck KH, Scherer SS. The effects of a dominant connexin32 mutant in myelinating Schwann cells. Molecular and Cellular Neurosciences. 32: 283-98. PMID 16790356 DOI: 10.1016/j.mcn.2006.05.001  1
2006 Barkovich AJ, Messing A. Alexander disease: not just a leukodystrophy anymore. Neurology. 66: 468-9. PMID 16505295 DOI: 10.1212/01.wnl.0000200905.43191.4d  1
2006 de Leeuw B, Su M, ter Horst M, Iwata S, Rodijk M, Hoeben RC, Messing A, Smitt PS, Brenner M. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements. Journal of Neuroscience Research. 83: 744-53. PMID 16496373 DOI: 10.1002/jnr.20776  1
2006 Wrabetz L, D'Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, Previtali S, Imperiale D, Zielasek J, Toyka K, Avila RL, Kirschner DA, Messing A, Feltri ML, Quattrini A. Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2358-68. PMID 16495463 DOI: 10.1523/JNEUROSCI.3819-05.2006  1
2006 Lee Y, Su M, Messing A, Brenner M. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene. Glia. 53: 677-87. PMID 16482522 DOI: 10.1002/glia.20320  1
2006 Li R, Johnson AB, Salomons GS, van der Knaap MS, Rodriguez D, Boespflug-Tanguy O, Gorospe JR, Goldman JE, Messing A, Brenner M. Propensity for paternal inheritance of de novo mutations in Alexander disease. Human Genetics. 119: 137-44. PMID 16365765 DOI: 10.1007/s00439-005-0116-7  1
2005 Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A, Parada LF. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell. 8: 119-30. PMID 16098465 DOI: 10.1016/j.ccr.2005.07.004  1
2005 Hagemann TL, Gaeta SA, Smith MA, Johnson DA, Johnson JA, Messing A. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Human Molecular Genetics. 14: 2443-58. PMID 16014634 DOI: 10.1093/hmg/ddi248  1
2005 Yue Q, Groszer M, Gil JS, Berk AJ, Messing A, Wu H, Liu X. PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development (Cambridge, England). 132: 3281-91. PMID 15944184 DOI: 10.1242/dev.01891  1
2005 van der Knaap MS, Salomons GS, Li R, Franzoni E, Gutiérrez-Solana LG, Smit LM, Robinson R, Ferrie CD, Cree B, Reddy A, Thomas N, Banwell B, Barkhof F, Jakobs C, Johnson A, ... Messing A, et al. Unusual variants of Alexander's disease. Annals of Neurology. 57: 327-38. PMID 15732098 DOI: 10.1002/ana.20381  1
2005 Li R, Johnson AB, Salomons G, Goldman JE, Naidu S, Quinlan R, Cree B, Ruyle SZ, Banwell B, D'Hooghe M, Siebert JR, Rolf CM, Cox H, Reddy A, Gutiérrez-Solana LG, ... ... Messing A, et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Annals of Neurology. 57: 310-26. PMID 15732097 DOI: 10.1002/ana.20406  1
2005 Connor JX, McCormack K, Pletsch A, Gaeta S, Ganetzky B, Chiu SY, Messing A. Genetic modifiers of the Kv beta2-null phenotype in mice. Genes, Brain, and Behavior. 4: 77-88. PMID 15720404 DOI: 10.1111/j.1601-183X.2004.00094.x  1
2005 Scherer SS, Xu YT, Messing A, Willecke K, Fischbeck KH, Jeng LJ. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 1550-9. PMID 15703409 DOI: 10.1523/JNEUROSCI.3082-04.2005  1
2005 Pleasure D, Messing A. Diphtheritic Polyneuropathy Peripheral Neuropathy. 2: 2147-2151. DOI: 10.1016/B978-0-7216-9491-7.50098-3  1
2004 Su M, Hu H, Lee Y, d'Azzo A, Messing A, Brenner M. Expression specificity of GFAP transgenes. Neurochemical Research. 29: 2075-93. PMID 15662842 DOI: 10.1007/s11064-004-6881-1  1
2004 Anton ES, Ghashghaei HT, Weber JL, McCann C, Fischer TM, Cheung ID, Gassmann M, Messing A, Klein R, Schwab MH, Lloyd KC, Lai C. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nature Neuroscience. 7: 1319-28. PMID 15543145 DOI: 10.1038/nn1345  1
2004 Taveggia C, Pizzagalli A, Fagiani E, Messing A, Feltri ML, Wrabetz L. Characterization of a Schwann cell enhancer in the myelin basic protein gene. Journal of Neurochemistry. 91: 813-24. PMID 15525335 DOI: 10.1111/j.1471-4159.2004.02745.x  1
2004 Smith SR, Cooperman S, Lavaute T, Tresser N, Ghosh M, Meyron-Holtz E, Land W, Ollivierre H, Jortner B, Switzer R, Messing A, Rouault TA. Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Annals of the New York Academy of Sciences. 1012: 65-83. PMID 15105256 DOI: 10.1196/annals.1306.006  1
2004 Yin X, Kidd GJ, Pioro EP, McDonough J, Dutta R, Feltri ML, Wrabetz L, Messing A, Wyatt RM, Balice-Gordon RJ, Trapp BD. Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3890-8. PMID 15084670 DOI: 10.1523/JNEUROSCI.4617-03.2004  1
2003 Messing A, Brenner M. Alexander disease: GFAP mutations unify young and old. The Lancet. Neurology. 2: 75. PMID 12849260 DOI: 10.1016/S1474-4422(03)00301-6  1
2003 Voskuhl RR, Pribyl TM, Kampf K, Handley V, Liu HB, Feng J, Campagnoni CW, Soldan SS, Messing A, Campagnoni AT. Experimental autoimmune encephalomyelitis relapses are reduced in heterozygous golli MBP knockout mice. Journal of Neuroimmunology. 139: 44-50. PMID 12799019 DOI: 10.1016/S0165-5728(03)00161-9  1
2003 Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron. 38: 747-58. PMID 12797959 DOI: 10.1016/S0896-6273(03)00301-5  1
2003 Messing A, Brenner M. GFAP: functional implications gleaned from studies of genetically engineered mice. Glia. 43: 87-90. PMID 12761871 DOI: 10.1002/glia.10219  1
2003 Theis M, Jauch R, Zhuo L, Speidel D, Wallraff A, Döring B, Frisch C, Söhl G, Teubner B, Euwens C, Huston J, Steinhäuser C, Messing A, Heinemann U, Willecke K. Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 766-76. PMID 12574405  1
2003 Messing A, Brenner M. Models of Alexander Disease Myelin Biology and Disorders. 2: 1115-1124. DOI: 10.1016/B978-012439510-7/50099-1  1
2002 Li R, Messing A, Goldman JE, Brenner M. GFAP mutations in Alexander disease. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 20: 259-68. PMID 12175861 DOI: 10.1016/S0736-5748(02)00019-9  1
2002 Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 418: 422-5. PMID 12140559 DOI: 10.1038/nature00838  1
2002 Gorospe JR, Naidu S, Johnson AB, Puri V, Raymond GV, Jenkins SD, Pedersen RC, Lewis D, Knowles P, Fernandez R, De Vivo D, van der Knaap MS, Messing A, Brenner M, Hoffman EP. Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology. 58: 1494-500. PMID 12034785  1
2002 Lesche R, Groszer M, Gao J, Wang Y, Messing A, Sun H, Liu X, Wu H. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis (New York, N.Y. : 2000). 32: 148-9. PMID 11857804 DOI: 10.1002/gene.10036  1
2002 McCormack K, Connor JX, Zhou L, Ho LL, Ganetzky B, Chiu SY, Messing A. Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 2 (Kcnab2). The Journal of Biological Chemistry. 277: 13219-28. PMID 11825900 DOI: 10.1074/jbc.M111465200  1
2002 Feltri ML, Graus Porta D, Previtali SC, Nodari A, Migliavacca B, Cassetti A, Littlewood-Evans A, Reichardt LF, Messing A, Quattrini A, Mueller U, Wrabetz L. Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. The Journal of Cell Biology. 156: 199-209. PMID 11777940 DOI: 10.1083/jcb.200109021  1
2001 Messing A, Brenner M, Johnson AB, Goldman JE. Update on white matter genetic disorders. Pediatric Neurology. 25: 347-8; author reply . PMID 11704412  1
2001 Zhuo L, Theis M, Alvarez-Maya I, Brenner M, Willecke K, Messing A. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis (New York, N.Y. : 2000). 31: 85-94. PMID 11668683 DOI: 10.1002/gene.10008  1
2001 Rodriguez D, Gauthier F, Bertini E, Bugiani M, Brenner M, N'guyen S, Goizet C, Gelot A, Surtees R, Pedespan JM, Hernandorena X, Troncoso M, Uziel G, Messing A, Ponsot G, et al. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. American Journal of Human Genetics. 69: 1134-40. PMID 11567214 DOI: 10.1086/323799  1
2001 Messing A, Goldman JE, Johnson AB, Brenner M. Alexander disease: new insights from genetics. Journal of Neuropathology and Experimental Neurology. 60: 563-73. PMID 11398833  1
2001 Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nature Genetics. 27: 117-20. PMID 11138011 DOI: 10.1038/83679  1
2000 Previtali SC, Quattrini A, Fasolini M, Panzeri MC, Villa A, Filbin MT, Li W, Chiu SY, Messing A, Wrabetz L, Feltri ML. Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice. The Journal of Cell Biology. 151: 1035-46. PMID 11086005 DOI: 10.1083/jcb.151.5.1035  1
2000 Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D'Antonio M, Martini R, Yin X, Trapp BD, Zhou L, Chiu SY, Messing A. P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. The Journal of Cell Biology. 148: 1021-34. PMID 10704451 DOI: 10.1083/jcb.148.5.1021  1
2000 Yin X, Kidd GJ, Wrabetz L, Feltri ML, Messing A, Trapp BD. Schwann cell myelination requires timely and precise targeting of P(0) protein. The Journal of Cell Biology. 148: 1009-20. PMID 10704450 DOI: 10.1083/jcb.148.5.1009  1
2000 Gonatas JO, Stieber A, Gonatas NK, Messing A. The golgi apparatus is present in perisynaptic, subependymal and perivascular processes of astrocytes and in processes of retinal Müller glia. Brain Research. 855: 23-31. PMID 10650126 DOI: 10.1016/S0006-8993(99)02037-5  1
2000 Previtali SC, Quattrini A, Fasolini M, Imperiale D, Panzeri C, Villa A, Messing A, Canal N, Wrabetz L, Feltri ML. Normal P0 glycoprotein rescues pathological effects of mutant P0 in a transgenic mouse model of CMT1B Neurological Sciences. 21: S97.  1
1999 Chiu SY, Zhou L, Zhang CL, Messing A. Analysis of potassium channel functions in mammalian axons by gene knockouts. Journal of Neurocytology. 28: 349-64. PMID 10739576  1
1999 Arroyo EJ, Xu YT, Zhou L, Messing A, Peles E, Chiu SY, Scherer SS. Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. Journal of Neurocytology. 28: 333-47. PMID 10739575  1
1999 Quattrini A, Feltri ML, Previtali S, Fasolini M, Messing A, Wrabetz L. Peripheral nerve dysmyelination due to P0 glycoprotein overexpression is dose-dependent. Annals of the New York Academy of Sciences. 883: 294-301. PMID 10586254  1
1999 Feltri ML, D'Antonio M, Previtali S, Fasolini M, Messing A, Wrabetz L. P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Annals of the New York Academy of Sciences. 883: 116-23. PMID 10586237  1
1999 Abel A, Bone LJ, Messing A, Scherer SS, Fischbeck KH. Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. Journal of Neuropathology and Experimental Neurology. 58: 702-10. PMID 10411340  1
1999 Zhou L, Messing A, Chiu SY. Determinants of excitability at transition zones in Kv1.1-deficient myelinated nerves. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5768-81. PMID 10407018  1
1999 Feltri ML, D'antonio M, Quattrini A, Numerato R, Arona M, Previtali S, Chiu SY, Messing A, Wrabetz L. A novel P0 glycoprotein transgene activates expression of lacZ in myelin-forming Schwann cells. The European Journal of Neuroscience. 11: 1577-86. PMID 10215910 DOI: 10.1046/j.1460-9568.1999.00568.x  1
1999 Zhang CL, Messing A, Chiu SY. Specific alteration of spontaneous GABAergic inhibition in cerebellar purkinje cells in mice lacking the potassium channel Kv1. 1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2852-64. PMID 10191303  1
1999 Xu K, Malouf AT, Messing A, Silver J. Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid. Glia. 25: 390-403. PMID 10028921 DOI: 10.1002/(SICI)1098-1136(19990215)25:4<390::AID-GLIA8>3.0.CO;2-7  1
1999 Wakabayashi T, Messing A, Brenner M. Nonlethal detection of transgene expression in the CNS of founder mice. Biotechniques. 26: 302-4, 306-7. PMID 10023542  1
1999 Messing A. Nestin in the liver--lessons from the brain. Hepatology (Baltimore, Md.). 29: 602-3. PMID 9918942 DOI: 10.1002/hep.510290234  1
1998 Messing A. Transgenic studies of peripheral and central glia. The International Journal of Developmental Biology. 42: 1019-24. PMID 9853833  1
1998 Harding CO, Wild K, Chang D, Messing A, Wolff JA. Metabolic engineering as therapy for inborn errors of metabolism--development of mice with phenylalanine hydroxylase expression in muscle. Gene Therapy. 5: 677-83. PMID 9797873 DOI: 10.1038/sj.gt.3300653  1
1998 Zhou L, Zhang CL, Messing A, Chiu SY. Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 7200-15. PMID 9736643  1
1998 Eng LF, Lee YL, Kwan H, Brenner M, Messing A. Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers. Journal of Neuroscience Research. 53: 353-60. PMID 9698163 DOI: 10.1002/(SICI)1097-4547(19980801)53:3<353::AID-JNR9>3.0.CO;2-9  1
1998 Nawashiro H, Messing A, Azzam N, Brenner M. Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury. Neuroreport. 9: 1691-6. PMID 9665584  1
1998 Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, Chiu SY, Schwartzkroin PA, Messing A, Tempel BL. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron. 20: 809-19. PMID 9581771 DOI: 10.1016/S0896-6273(00)81018-1  1
1998 Wrabetz L, Taveggia C, Feltri ML, Quattrini A, Awatramani R, Scherer SS, Messing A, Kamholz J. A minimal human MBP promoter-lacZ transgene is appropriately regulated in developing brain and after optic enucleation, but not in shiverer mutant mice. Journal of Neurobiology. 34: 10-26. PMID 9469615 DOI: 10.1002/(SICI)1097-4695(199801)34:1<10::AID-NEU2>3.0.CO;2-F  1
1998 Messing A, Head MW, Galles K, Galbreath EJ, Goldman JE, Brenner M. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. The American Journal of Pathology. 152: 391-8. PMID 9466565  1
1997 Wang X, Messing A, David S. Axonal and nonneuronal cell responses to spinal cord injury in mice lacking glial fibrillary acidic protein. Experimental Neurology. 148: 568-76. PMID 9417833 DOI: 10.1006/exnr.1997.6702  1
1997 Carpenter MK, Winkler C, Fricker R, Emerich DF, Wong SC, Greco C, Chen EY, Chu Y, Kordower JH, Messing A, Björklund A, Hammang JP. Generation and transplantation of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice. Experimental Neurology. 148: 187-204. PMID 9398461 DOI: 10.1006/exnr.1997.6657  1
1997 Vabnick I, Messing A, Chiu SY, Levinson SR, Schachner M, Roder J, Li C, Novakovic S, Shrager P. Sodium channel distribution in axons of hypomyelinated and MAG null mutant mice. Journal of Neuroscience Research. 50: 321-36. PMID 9373041 DOI: 10.1002/(SICI)1097-4547(19971015)50:2<321::AID-JNR20>3.0.CO;2-9  1
1997 Kordower JH, Chen EY, Winkler C, Fricker R, Charles V, Messing A, Mufson EJ, Wong SC, Rosenstein JM, Björklund A, Emerich DF, Hammang J, Carpenter MK. Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease. The Journal of Comparative Neurology. 387: 96-113. PMID 9331174 DOI: 10.1002/(SICI)1096-9861(19971013)387:1<96::AID-CNE8>3.0.CO;2-I  1
1997 Peachey NS, Roveri L, Messing A, McCall MA. Functional consequences of oncogene-induced horizontal cell degeneration in the retinas of transgenic mice. Visual Neuroscience. 14: 627-32. PMID 9278992  1
1997 Zhuo L, Sun B, Zhang CL, Fine A, Chiu SY, Messing A. Live astrocytes visualized by green fluorescent protein in transgenic mice. Developmental Biology. 187: 36-42. PMID 9224672 DOI: 10.1006/dbio.1997.8601  1
1997 Zhuo L, Messing A, Azen EA. Proline-rich-protein promoters direct LacZ expression to the granular convoluted tubular cells of the submandibular gland in adult transgenic mice. Transgenic Research. 6: 19-25. PMID 9032974  1
1996 Brenner M, Messing A. GFAP Transgenic Mice Methods (San Diego, Calif.). 10: 351-64. PMID 8954847 DOI: 10.1006/meth.1996.0113  1
1996 Gregg RG, Messing A, Strube C, Beurg M, Moss R, Behan M, Sukhareva M, Haynes S, Powell JA, Coronado R, Powers PA. Absence of the beta subunit (cchb1) of the skeletal muscle dihydropyridine receptor alters expression of the alpha 1 subunit and eliminates excitation-contraction coupling. Proceedings of the National Academy of Sciences of the United States of America. 93: 13961-6. PMID 8943043 DOI: 10.1073/pnas.93.24.13961  1
1996 Delaney CL, Brenner M, Messing A. Conditional ablation of cerebellar astrocytes in postnatal transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 6908-18. PMID 8824329  1
1996 McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proceedings of the National Academy of Sciences of the United States of America. 93: 6361-6. PMID 8692820 DOI: 10.1073/pnas.93.13.6361  1
1996 Schwartz JP, Taniwaki T, Messing A, Brenner M. Somatostatin as a trophic factor. Analysis of transgenic mice overexpressing somatostatin in astrocytes. Annals of the New York Academy of Sciences. 780: 29-35. PMID 8602737  1
1996 Roveri L, Peachey NS, Messing A, McCall MA. Visual transmission following horizontal cell ablation Investigative Ophthalmology and Visual Science. 37: S699.  1
1995 Zhou R, Assouline JG, Abbas PJ, Messing A, Gantz BJ. Anatomical and physiological measures of auditory system in mice with peripheral myelin deficiency. Hearing Research. 88: 87-97. PMID 8576008 DOI: 10.1016/0378-5955(95)00104-C  1
1995 Comerford SA, Maika SD, Laimins LA, Messing A, Elsässer HP, Hammer RE. E6 and E7 expression from the HPV 18 LCR: development of genital hyperplasia and neoplasia in transgenic mice. Oncogene. 10: 587-97. PMID 7845684  1
1995 Galbreath E, Kim SJ, Park K, Brenner M, Messing A. Overexpression of TGF-beta 1 in the central nervous system of transgenic mice results in hydrocephalus. Journal of Neuropathology and Experimental Neurology. 54: 339-49. PMID 7745433  1
1994 Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A. GFAP promoter directs astrocyte-specific expression in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 1030-7. PMID 8120611  1
1994 Wilkie TM, Schmidt RA, Baetscher M, Messing A. Smooth muscle and bone neoplasms in transgenic mice expressing SV40 T antigen. Oncogene. 9: 2889-95. PMID 8084593  1
1994 Cole JS, Messing A, Trojanowski JQ, Lee VM. Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 6956-66. PMID 7965091  1
1994 Chiu SY, Scherer SS, Blonski M, Kang SS, Messing A. Axons regulate the expression of Shaker-like potassium channel genes in Schwann cells in peripheral nerve. Glia. 12: 1-11. PMID 7843783 DOI: 10.1002/glia.440120102  1
1994 Messing A, Behringer RR, Wrabetz L, Hammang JP, Lemke G, Palmiter RD, Brinster RL. Hypomyelinating peripheral neuropathies and schwannomas in transgenic mice expressing SV40 T-antigen. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 3533-9. PMID 7515952  1
1994 Fung KM, Chikaraishi DM, Suri C, Theuring F, Messing A, Albert DM, Lee VM, Trojanowski JQ. Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 70: 114-24. PMID 7508007  1
1993 Hammang JP, Behringer RR, Baetge EE, Palmiter RD, Brinster RL, Messing A. Oncogene expression in retinal horizontal cells of transgenic mice results in a cascade of neurodegeneration. Neuron. 10: 1197-209. PMID 8391281 DOI: 10.1016/0896-6273(93)90067-2  1
1993 Hammang JP, Baetge EE, Messing A. Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter Neuroprotocols. 3: 176-183. DOI: 10.1006/ncmn.1993.1052  1
1992 Hammang JP, Bohn MC, Messing A. Phenylethanolamine N-methyltransferase (PNMT)-expressing horizontal cells in the rat retina: a study employing double-label immunohistochemistry. The Journal of Comparative Neurology. 316: 383-9. PMID 1577991 DOI: 10.1002/cne.903160309  1
1992 Fung KM, Messing A, Lee VM, Trojanowski JQ. A novel modification of the avidin-biotin complex method for immunohistochemical studies of transgenic mice with murine monoclonal antibodies. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 40: 1319-28. PMID 1506669  1
1992 Davis BP, Hammer RE, Messing A, MacDonald RJ. Selective expression of trypsin fusion genes in acinar cells of the pancreas and stomach of transgenic mice. The Journal of Biological Chemistry. 267: 26070-7. PMID 1464618  1
1992 Messing A, Behringer RR, Hammang JP, Palmiter RD, Brinster RL, Lemke G. P0 promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice. Neuron. 8: 507-20. PMID 1372510 DOI: 10.1016/0896-6273(92)90279-M  1
1991 Hammang JP, Messing A. Immortalized retinal neurons used as immunogen for the generation of cell-specific antisera. Brain Research. 556: 85-94. PMID 1718559 DOI: 10.1016/0006-8993(91)90550-F  1
1990 Hammang JP, Baetge EE, Behringer RR, Brinster RL, Palmiter RD, Messing A. Immortalized retinal neurons derived from SV40 T-antigen-induced tumors in transgenic mice. Neuron. 4: 775-82. PMID 2344410 DOI: 10.1016/0896-6273(90)90204-S  1
1990 Messing A. Modeling Schwann cell diseases in transgenic mice. Annals of the New York Academy of Sciences. 605: 325-31. PMID 1702605  1
1989 Dyer KR, Messing A. Metal-inducible pathology in the liver, pancreas, and kidney of transgenic mice expressing SV40 early region genes. The American Journal of Pathology. 135: 401-10. PMID 2782379  1
1989 Dyer KR, Messing A. Peripheral neuropathy associated with functional islet cell adenomas in SV40 transgenic mice. Journal of Neuropathology and Experimental Neurology. 48: 399-412. PMID 2543797  1
1988 Messing A, Pinkert CA, Palmiter RD, Brinster RL. Developmental study of SV40 large T antigen expression in transgenic mice with choroid plexus neoplasia. Oncogene Research. 3: 87-97. PMID 3060799  1
1988 Baetge EE, Behringer RR, Messing A, Brinster RL, Palmiter RD. Transgenic mice express the human phenylethanolamine N-methyltransferase gene in adrenal medulla and retina. Proceedings of the National Academy of Sciences of the United States of America. 85: 3648-52. PMID 2835776  1
1988 Behringer RR, Peschon JJ, Messing A, Gartside CL, Hauschka SD, Palmiter RD, Brinster RL. Heart and bone tumors in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 85: 2648-52. PMID 2833748  1
1987 Ornitz DM, Hammer RE, Messing A, Palmiter RD, Brinster RL. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science (New York, N.Y.). 238: 188-93. PMID 2821617  1
1985 Messing A, Stieber A, Gonatas NK. Resolution of diaminobenzidine for the detection of horseradish peroxidase on surfaces of cultured cells. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 33: 837-9. PMID 3894500  1
1985 Ornitz DM, Palmiter RD, Messing A, Hammer RE, Pinkert CA, Brinster RL. Elastase I promoter directs expression of human growth hormone and SV40 T antigen genes to pancreatic acinar cells in transgenic mice. Cold Spring Harbor Symposia On Quantitative Biology. 50: 399-409. PMID 3006998  1
1985 Messing A, Chen HY, Palmiter RD, Brinster RL. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice. Nature. 316: 461-3. PMID 2991772 DOI: 10.1038/316461a0  1
1985 Palmiter RD, Chen HY, Messing A, Brinster RL. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature. 316: 457-60. PMID 2991771 DOI: 10.1038/316457a0  1
1984 Messing A, Bizzini B, Gonatas NK. Concanavalin A inhibits nicotinic acetylcholine receptor function in cultured chick ciliary ganglion neurons. Brain Research. 303: 241-9. PMID 6331572 DOI: 10.1016/0006-8993(84)91210-1  1
1983 Messing A, Gonatas NK. Extra-synaptic localization of alpha-bungarotoxin receptors in cultured chick ciliary ganglion neurons. Brain Research. 269: 172-6. PMID 6191837 DOI: 10.1016/0006-8993(83)90977-0  1
1981 Kreider BQ, Messing A, Doan H, Kim SU, Lisak RP, Pleasure DE. Enrichment of Schwann cell cultures from neonatal rat sciatic nerve by differential adhesion. Brain Research. 207: 433-44. PMID 7008901 DOI: 10.1016/0006-8993(81)90375-9  1
Show low-probability matches.